Skip to main navigation

Press Releases

Press Releases

Year

Dec 04, 2023

Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives

Nov 28, 2023

Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing

Nov 16, 2023

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

Nov 07, 2023

Personalis Reports Third Quarter 2023 Financial Results

Oct 26, 2023

Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer

Oct 24, 2023

Personalis to Announce Third Quarter 2023 Financial Results

Oct 21, 2023

Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology

Oct 19, 2023

Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023

Oct 18, 2023

Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance

Aug 29, 2023

Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Displaying 1 - 10 of 31

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website